Alnylam and Monsanto form strategic alliance

Tuesday, August 28, 2012

St. Louis-based Monsanto and Alnylam Pharmaceuticals of Cambridge, Mass., have formed a strategic alliance to advance biological technologies in the field of agriculture. The new alliance brings Alnylam’s broad RNAi-based intellectual property (IP) and proprietary technologies to Monsanto’s new BioDirect technology, which aims to deliver innovative biological solutions for farmers.

[Read More]